[Association of drug resistance of Mycoplasma pneumoniae with DNA load and genotypes in children with Mycoplasma pneumoniae pneumonia]
- PMID: 29132466
- PMCID: PMC7389332
- DOI: 10.7499/j.issn.1008-8830.2017.11.011
[Association of drug resistance of Mycoplasma pneumoniae with DNA load and genotypes in children with Mycoplasma pneumoniae pneumonia]
Abstract
Objective: To investigate the association of drug resistance of Mycoplasma pneumoniae (MP) with DNA load and genotypes in children with MP pneumonia.
Methods: A total of 230 children who were hospitalized and diagnosed with MP pneumonia between January 2012 and December 2016 were enrolled. Throat swabs were collected from the 230 children, and a rapid drug sensitivity assay was used to determine the sensitivity of clinical isolates of MP to nine commonly used antibacterial agents. Quantitative real-time PCR was used to measure MP-DNA load in throat swabs. PCR sequencing was used to determine the genotype of 2063 locus of the MP 23S rRNA V domain.
Results: Of the 230 children, 86 (37.4%) had genotype A in 2063 locus, 134 (58.3%) had genotype G, 8 (3.5%) had genotype C, and 2 (0.9%) had genotype T. Mutant strains (genotype G+C+T) had a significantly higher MP-DNA load than wild-type strains (genotype A) (P<0.05). The strains resistant to erythromycin, azithromycin, clarithromycin, and clindamycin had a significantly higher MP-DNA load than non-resistant strains (P<0.05). MP had a high drug resistance rate to macrolide antibiotics. More than 60% of the cases with resistance to macrolides were found to have A2063G mutations. MP was rarely resistant to quinolones (less than 2%).
Conclusions: Mutations in 2063 locus of the MP 23S rRNA V domain may result in the resistance of MP to macrolides and the change in DNA load and can be used as a basis for selecting drugs for MP.
目的: 探讨肺炎支原体(MP)肺炎患儿MP耐药情况及其与DNA载量和基因型的关系。
方法: 选取2012年1月至2016年12月诊断为MP肺炎的230例住院患儿为研究对象,采集所有患儿咽拭子标本,采用快速培养基培养药敏法测定9种常用抗菌药物对MP临床分离株的药物敏感性;荧光实时定量PCR检测患儿咽拭子MP-DNA载量;PCR测序检测MP 23S rRNA V区2063位基因型。
结果: 230例MP患儿中,86例2063位基因型为A(37.4%),134例为G(58.3%),8例为C(3.5%),2例为T(0.9%)。突变基因型(G+C+T)MP-DNA载量高于野生基因型(A)菌株(P < 0.05);红霉素、阿奇霉素、克拉霉素、克林霉素耐药组MP-DNA载量高于非耐药组(P < 0.05)。MP对大环内酯类抗生素耐药率较高,60%以上产生大环内酯类耐药的病例均检测出A2063G突变,喹诺酮类药物少见MP耐药(低于2%)。
结论: 23S rRNA V区2063位点发生基因突变可能导致MP对大环内酯类药物耐药和DNA载量的变化,可作为MP治疗用药的选择依据。
References
-
- 辛 德莉, 史 大伟. 耐药肺炎支原体感染的抗生素治疗进展. http://doi.med.wanfangdata.com.cn/10.3760/cma.j.issn.1673-4408.2008.03.011. 中华实用儿科临床杂志. 2013;28(22):1695–1697.
-
- 郑 杨, 崔 红. 肺炎支原体耐药机制的研究现状. 中国医刊. 2009;44(12):18–20.
-
- 辛 德莉, 韩 旭, 糜 祖煌, et al. 肺炎支原体对大环内酯类抗生素耐药性及耐药机制研究. http://industry.wanfangdata.com.cn/dl/Detail/Periodical?id=Periodical_zh... 中华检验医学杂志. 2008;31(5):543–546.
-
- 冯 真英, 叶 少玲, 陈 文兴, et al. 肺炎支原体对大环内酯类抗生素耐药性及耐药机制研究. http://industry.wanfangdata.com.cn/dl/Detail/Periodical?id=Periodical_zh... 中国现代药物应用. 2016;10(13):137–139.
-
- 孔 洁, 陈 友国, 管 敏昌, et al. 肺炎支原体23S rRNA耐药基因2063位点阳性的肺炎支原体肺炎患儿临床特征及BALF中IL-8表达. 中国卫生检验杂志. 2016;26(23):3385–3388.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
